Traditional MS drug therapies used up through and until the mid 1990’s were all immunosuppressives.  Fingolimod or FTY720 multiple sclerosis treatment has been studied since it was first synthesized in 1992.  FTY720 MS therapy belongs to the group of drugs known as immunomodulators.  That is to say it is like the so-called ABC drugs that started to be used in the mid-nineties.  These drugs – Avonex, Betaseron, and Copaxone are also in the category of immunomodulators.  While the traditional immunosuppressives would treat the immune system as an entire system, or globally, these ABC drugs fight a specific part of the immune system that has become overactive in relation to MS.  But Fingolimod or FTY720 multiple sclerosis, (MS) treatment is newer.  In fact, it didn’t gain approval until 2010 in the US and 2011 in Europe, Canada, and Australia.  Originally developed as an anti rejection medication for post-transplant patients, it was …